非硫酸HNK-1甘氨酸在尿液中的分泌与功能障碍有关
Hajime Okayama1, Nanako Iikura1, Daisuke Takakura2
1Human Health Sciences, Graduate School of Medicine, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Journal of biochemistry
|February 2, 2026
概括
尿中非硫化的人类天然杀手-1 (nsHNK-1) 甘氨酸,由美林A亚单元α (MEP1A) 携带,可在小鼠中检测到. 它的水平与损伤相关,这表明它有可能成为一种新的生物标志物.
科学领域:
- 葡萄糖生物学 葡萄糖生物学
- 脏生理学 脏生理学
- 生物标志物发现发现
背景情况:
- 非硫化人类天然杀手-1 (nsHNK-1) 甘氨酸在小鼠脏的近端管道中表达.
- 已知膜蛋白质的尿液分泌,但尿液nsHNK-1糖仍未研究.
研究的目的:
- 为了研究小鼠尿液中nsHNK-1甘氨酸的存在和重要性.
- 为了识别尿道nsHNK-1糖的载体蛋白质.
- 探索nsHNK-1糖化酶的功能作用及其作为功能生物标志物的潜力.
主要方法:
- 在小鼠尿液中检测nsHNK-1甘氨酸.
- 使用质谱学识别MEP1A作为主要载体蛋白.
- 在GlcAT-S淘汰赛小鼠和诱导损伤 (管状和状) 后分析nsHNK-1甘氨酸水平.
主要成果:
- 在小鼠尿液中可以检测到nsHNK-1甘氨酸,主要与美素A亚单元α (MEP1A) 相关.
- MEP1A在四个部位携带nsHNK-1,特别是Asn221.1.
- GlcAT-S淘汰赛小鼠在MEP1A上显示出尿中nsHNK-1缺失,酶活性降低.
- 管管损伤减少了尿路MEP1A相关的nsHNK-1,而球损伤增加了它.
结论:
- 对于MEP1A的nsHNK-1糖基化具有功能意义.
- 尿中的nsHNK-1水平,反映了MEP1A糖化,差异性地表明功能障碍.
- 尿道nsHNK-1可能作为评估功能的一种新生物标志物.
相关概念视频
Renal Drug Excretion: Overview
709
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
709
Renal Drug Clearance: Comparison Between Renal Excretion Methods
611
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
611
Renal Drug Excretion: Glomerular Filtration
1.3K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
1.3K
Renal Drug Excretion: Tubular Reabsorption
850
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
850
Renal Drug Excretion: Tubular Secretion
880
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
880
One-Compartment Open Model: Urinary Excretion Data and Determination of k
629
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
629


